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Despite the universality of tRNA modiﬁcations, some tRNAs lacking speciﬁc modiﬁcations are sub-
ject to degradation pathways, while other tRNAs lacking the same modiﬁcations are resistant. Here,
we suggest a model in which some modiﬁcations have minor, possibly redundant, roles in speciﬁc
tRNAs. This model is consistent with the low speciﬁcity of some modiﬁcation enzymes. Limitations
of this model include the limited assays and growth conditions on which these conclusions are
based, as well as the high speciﬁcity exhibited by many modiﬁcation enzymes with important roles
in translation. The speciﬁcity of these enzymes is often enhanced by complex substrate recognition
patterns and sub-cellular compartmentalization.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
tRNA modiﬁcations are universal. All characterized tRNA spe-
cies bear numerous modiﬁcations of their bases and of their corre-
sponding ribose moieties. Modiﬁcations are found on 11.9% of the
residues of the 561 sequenced tRNAs, with a median of eight modi-
ﬁcations per tRNA [1]. This data set includes tRNAs from a wide
range of organisms, including archaea (59 tRNAs), eubacteria
(135), fungi (65), animals (111) and plants (44), as well as from
chloroplasts (35), mitochondria (95) and viruses (17). Furthermore,
this data set includes tRNAs with each different amino acid accep-
tor and each different anticodon within each of the phylogenetic
domains, and multiple tRNAs from several organisms. For example,
in the yeast Saccharomyces cerevisiae, 16.4% of the residues of the
34 sequenced cytoplasmic tRNA species bear modiﬁcations, with
a range from 7 to 17 modiﬁcations per tRNA, and 9.5% of the resi-
dues of the 17 sequenced mitochondrial tRNAs bear modiﬁcations,
with a range from 6 to 9 modiﬁcations per tRNA. Thus, these
results imply the universal occurrence of tRNA modiﬁcations. In
support of this claim, tRNA modiﬁcations are also conservedchemical Societies. Published by E
nter for RNA Biology and The
o State University, Columbus,
u (E.M. Phizicky), alfonzo.1@in the smallest free-living organisms [2], and in organisms living
in both extremely cold and extremely hot environments, although
modiﬁcations are much reduced in some organisms from cold
environments [3,4].
Many modiﬁcation enzymes act on multiple tRNA substrates,
catalyzing the same modiﬁcation at a particular position, or a de-
ﬁned set of positions, in different tRNA species of a single organ-
ism. This is illustrated by analysis of the modiﬁcations found in
cytoplasmic tRNAs of the yeast S. cerevisiae. In many cases one en-
zyme catalyzes all of the modiﬁcations of a particular type,
whether the modiﬁcation is only found at one position, or is found
at multiple positions in the tRNA. Thus, for example, Trm11/
Trm112 is responsible for each of the 20 known occurrences of
m2G, which are all at position 10 [5], Trm6/Trm61 (also called
Gcd10/Gcd14) is responsible for each of the 23 known occurrences
of m1A, which are at position 58 [6,7], the Elp-Kti complex is
responsible for each of the 11 occurrences of the cm5U moiety of
mcm5U, ncm5U, ncm5Um, and mcm5s2U, which are found at posi-
tion 34 [8–10] and Trm4 is responsible for all of the 30 known
occurrences of m5C, which are found at positions 34, 40, 48, and
49 [11]. In other cases, a group of two or more enzymes catalyzes
formation of the same modiﬁcation, and each enzyme is responsi-
ble for the subset of modiﬁcations that occur at a particular posi-
tion or set of positions. Thus, for example, Trm5 and Trm10 each
catalyze formation of the subset of the 18 characterized m1G
modiﬁcations that occur at G37 and G9, respectively [12,13],lsevier B.V. All rights reserved.
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characterized dihydrouridine modiﬁcations that occur at positions
16 and 17, 20, 20a and 20b, and 47, respectively [14], and six pseu-
douridylases catalyze formation of the 102 characterized pseudou-
ridine modiﬁcations, each acting at a subset of the 15 different
positions with this modiﬁcation [15–20].
Whereas many of the modiﬁcations around the anticodon have
signiﬁcant effects on translation or translation ﬁdelity [10,21–24],
a large body of physical evidence supports the claim that modiﬁca-
tions are also important for the folding and stability of tRNAs.
When compared to native modiﬁed tRNA, completely unmodiﬁed
tRNA has a reduced Tm of 5 C, has reduced tertiary interactions
at low Mg2+ concentrations, and is more dynamic [25–32]. The sta-
bilization effects of modiﬁcations are almost certainly due to body
modiﬁcations (those that are in the central core of the tRNA and re-
mote from the anticodon), since residues in the anticodon region
do not interact with the main body of the tRNA.
Examination of individual modiﬁcations supports the claim that
modiﬁcations have a role in stabilizing tRNA structure and/or fold-
ing. Thus T54 instead of U54 leads to a 6 C increase in the Tm of
Escherichia coli tRNAfMet [33] and a 2 C increase in the Tm of an
otherwise unmodiﬁed T-stem-loop oligonucleotide [34], and each
of T54, W55 and m5C49 in an otherwise unmodiﬁed tRNAPhe 30
half-molecule contribute signiﬁcantly to the binding afﬁnity for
the unmodiﬁed 50 half of the tRNA [35]. Furthermore, model stud-
ies demonstrate that both pseudouridine and 20-O methylation
have stabilizing effects on helices [36–42], and that m1A9 promotes
correct folding of human mitochondrial tRNALys [43].
However, it is not clear from these studies if individual modiﬁ-
cations have quantitatively similar stabilizing or folding effects on
all tRNAs bearing the corresponding modiﬁcations. We describe
below in vivo evidence demonstrating that lack of certain speciﬁc
modiﬁcations in the body of tRNA has major effects on the stability
or function of only a small number of tRNA species with the corre-
sponding modiﬁcations, and only minor effects on other tRNAs
with the same modiﬁcations. We also summarize evidence for lack
of speciﬁcity for at least some modiﬁcation enzymes. These studies
thus suggest that perhaps the modiﬁcation of multiple species of
tRNA by a particular enzyme occurs as a result of overlapping sub-
strate speciﬁcity, and not necessarily because of equal evolutionary
demand for these modiﬁcations in all tRNAs. Then we point out the
caveats in these arguments, particularly, evidence suggesting that
modiﬁcations with a role in translation generally have speciﬁc
roles in each of their substrate tRNAs. We note, that in many of
these cases, the modiﬁcation activity itself is either highly speciﬁc
or additional layers of control regulate substrate speciﬁcity.2. Evidence suggesting that some modiﬁcations may have
quantitatively minor roles in some tRNAs
2.1. Lack of m7G and m5C leads to speciﬁc degradation of mature
tRNAVal(AAC)
We have shown that yeast cells lacking m7G46 and m5C due to
lack of Trm8 and Trm4 are temperature sensitive due to degrada-
tion and deacylation of mature tRNAVal(AAC) [44] by a rapid tRNA
decay pathway that is mediated by the 50–30 exonucleases Rat1
and Xrn1, and by Met22 [45]. Two lines of evidence suggest that
this degradation is speciﬁc for tRNAVal(AAC), and not other species
lacking m7G46 and m5C. First, the temperature sensitive phenotype
of trm8-D trm4-Dmutants can be restored by introduction of mul-
ticopy plasmids expressing tRNAVal(AAC) [44], strongly suggesting
that this tRNA is the only species that is adversely affected in the
mutant. Second, whereas the levels of tRNAVal(AAC) are reduced to
less than 20% of wild type levels in trm8-D trm4-Dmutants at hightemperature, the levels of a number of control tRNAs remain al-
most constant (Fig. 1), including all three tRNA species that, like
tRNAVal(AAC), have both m7G46 and m5C49 (tRNAPhe [45], tRNAiMet
[44] and tRNAVal(CAC) (J. Whipple and E.M.P., unpublished results),
and the three other known tRNAs with m7G46 and m5C at other
positions (tRNACys I.S. Chernyakov and E.M.P., unpublished results),
tRNALys(UUU) [44] and tRNAMet [44]).
These results demonstrate clearly that the combined loss of
m7G and m5C has only a minor effect on targeting other tRNAs
for degradation by the RTD pathway, and suggest that perhaps
these modiﬁcations have only minor stabilizing effects on the func-
tion of the resistant tRNAs. Presumably the modest but distinct
role of m5C of tRNAPhe in stabilizing binding between the two
halves of the tRNA [35] is not crucial in vivo under these condi-
tions. Presumably also, the known tertiary interactions between
m7G46 and G22 of the C13:G22 base pair of tRNAPhe are not grossly
perturbed by loss of methylation at m7G, since these interactions
involve donation of hydrogen bonds from the N1 and exocyclic
N2 position of the G46 residue [46], which are available in the pres-
ence or absence of the methyl group.2.2. Lack of ac4C12 and Um44 leads to speciﬁc degradation of mature
tRNASer(CGA) and tRNASer(UGA)
We have also previously shown that yeast cells lacking ac4C12
and Um44 due to lack of Tan1 and Trm44 are temperature sen-
sitive due to degradation of mature tRNASer(CGA) and tRNASer(UGA)
by the RTD pathway [47]. Two lines of evidence suggest that this
degradation is speciﬁc for these two tRNA species, and not the
two other tRNASer species. First, overproduction of tRNASer(CGA)
and tRNASer(UGA) restores healthy growth at high temperature.
Second, there is no observed reduction in levels of tRNASer(IGA),
the only other tRNA with both of these modiﬁcations, or of
tRNASer(GCA), the only other tRNA likely to have these modiﬁca-
tions [47]. In addition, tan1-D trm44-D strains have mildly
reduced levels of tRNALeu(GAG) at high temperature, presumably
due to the lack of ac4C12 since this tRNA does not have Um44;
however, none of the other three tRNALeu species (which are
the only other tRNA species with ac4C12) has reduced levels
under these conditions.2.3. Lack of m1A58 in tRNA appears to lead to speciﬁc degradation of
pre-tRNAi
Met in yeast
Anderson and co-workers have shown that pre-tRNAiMet lacking
m1A58 is recognized by a nuclear surveillance system in a trm6ts
mutant at non-permissive temperature, polyadenylated by Trf4
of the TRAMP complex, and degraded by Rrp6 and the nuclear
exosome [6,48,49].
Three lines of evidence suggest that the turnover of pre-tRNAiMet
lacking m1A58 by this nuclear surveillance system is speciﬁc for
tRNAiMet rather than the other species with m1A58. First, the nor-
mally essential Trm6/Trm61 m1A58 methyltransferase can be by-
passed by overproduction of initiator tRNA (tRNAiMet) from a
multicopy plasmid, demonstrating unequivocally that despite the
occurrence of m1A in 23 characterized yeast tRNAs, the only essen-
tial m1A modiﬁcation is that found on initiator tRNA [6]. Second,
degradation of pre-tRNAiMet in a trm6ts mutant is speciﬁc, since
steady state levels of several other tRNAs are unaffected under
these conditions, including tRNAMet, which has m1A, tRNAHis, which
does not have m1A, and tRNASer(CGA) and tRNAIle(UAU), which are not
characterized [6]. Second, treatment of RNA from a trm6 mutant
with the TRAMP complex and Rrp44 nuclease of the exosome,
results in polyadenylation and partial degradation of tRNAiMet, but
not of tRNATrp, tRNAPro(UGG), and tRNATyr, which have m1A, or
Fig. 1. Illustration of the speciﬁcity of the rapid tRNA degradation pathway. The ﬁgure depicts four yeast tRNAs known to have m7G46 and m5C49, only one of which is a
substrate for the rapid tRNA decay pathway in trm8-D trm4-D mutants, which lack these modiﬁcations. Mature tRNAVal(AAC) is rapidly degraded in trm8-D trm4-D mutants
upon shift to 37 C by the 50–30 exonucleases Rat1 or Xrn1, whereas tRNAPhe, tRNAVal(CAC), and tRNAiMet are resistant. Green circles represent each residue, yellow circles
represent known modiﬁcations, orange circles represent sites of m7G and m5C modiﬁcation, and the anticodon is colored to match its amino acid, indicated by an oval.
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sults suggest that lack of m1A primarily affects tRNAiMet.
Anderson and co-workers [49] have speculated that one plausi-
ble explanation for the speciﬁcity of the nuclear surveillance sys-
tem for pre-tRNAiMet lacking m1A58 is the unique T-loop
structure of tRNAiMet, which is not found in elongator tRNAs, and
involves hydrogen bonds between N6 and N7 of m1A58 with A54,
and O20 of m1A58 and A60 [51]. Lack of the methyl group of
m1A58 may have only minor consequences on elongator tRNA spe-
cies, which have a T54:A58 or a T54:m1A58 pair instead of the
A54:m1A58 pair [46,52]. Nonetheless, lack of Trm6 and m1A58 in
yeast is only partially overcome by overproduction of tRNAiMet,
since the cells still show a growth phenotype and are temperature
sensitive [6]. This suggests either that tRNAiMet lacking m1A58 is
still poorly functional, or that one or more other species of tRNA
is affected by lack of the m1A modiﬁcation.
All three cases examined above document clear evidence that
lack of modiﬁcations leads to degradation of speciﬁc tRNA species,
through the action of quality control pathways that degrade hypo-
modiﬁed pre-tRNA by the nuclear surveillance system, or mature
tRNA by the rapid tRNA decay pathway, with no reported observa-
ble effects on the levels of other tRNAs. These results imply that de-
spite the substantial body of evidence that modiﬁcations can
stabilize tRNA in vitro, the stabilizing effect of some of the modiﬁ-
cations may be either too minor to measure in vivo for many tRNAs
under conditions that have been tested, or redundant due to other
stabilizing structural features of the tRNA.
Evidence in vitro also suggests that certain tRNAmodiﬁcation en-
zymes can lack speciﬁcity. Thus, yeast Pus1 protein presumably has
low speciﬁcity because it is responsible formodiﬁcation of tRNA sub-
strates at a large number of positions (U1, U26, U27, U28, U32 U34, U35,
U36, U65 and U67) [20] as well as formodiﬁcation of U1RNA [53]. Sim-
ilarly, Trm4 is responsible for m5C modiﬁcation at C34, C40, C48 and
C49 in numerous tRNAs [11], as well as for modiﬁcation of C50 of
tRNAHis when Thg1 is depleted [54]. These examples emphasize
the rather low substrate speciﬁcity of some modiﬁcation enzymes.The in vivo and in vitro results described above suggest further
that there may be some modiﬁcations of tRNAs that occur as an
indirect consequence of the need to modify one or a few particular
tRNAs for which the modiﬁcation is crucial. According to this mod-
el, the modiﬁcation of other tRNA species that occurs as a conse-
quence of shared recognition features with the crucial tRNA
substrates, may confer little or no beneﬁcial (or deleterious) func-
tion to these other accidentally modiﬁed tRNAs.3. Non-essential body modiﬁcations may have unappreciated
roles
Despite the evidence described above suggesting the presence
of some possibly ancillary or redundant modiﬁcations in tRNAs,
it is important to recall that only a limited number of conditions
have been tested for the function of modiﬁcations in vivo. Thus,
although only speciﬁc tRNAs lacking particular modiﬁcations are
targeted for degradation, that is not to say that modiﬁcations of
the tRNA body only serve this one stabilizing role in the body
and always act to prevent degradation by these two pathways. It
is well known that modiﬁcations such as dihydrouridine can add
to tRNA ﬂexibility [3,55], that several modiﬁcations can affect the
speciﬁcity of aminoacyl tRNA synthetases [56–58], that modiﬁca-
tions can affect the folding of tRNA [43], and that modiﬁcations
can affect the activity and targeting of endotoxins [59]. Thus, it
seems plausible that other seemingly redundant modiﬁcations
may exert their effects in one of these ways or in different ways
on different tRNAs. It is also certainly possible that modiﬁcations
might act by affecting other functions of tRNA, such as their inter-
action with cellular trafﬁcking proteins, with translation elonga-
tion factors or with other components of the ribosome, or that
modiﬁcations play different or unanticipated roles in response to
different growth conditions, developmental states or stresses.
These roles of modiﬁcations will undoubtedly emerge as increas-
ingly sophisticated assays are used to probe function.
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modiﬁed tRNAs and are added in a highly speciﬁc manner
Several examples demonstrate that certain modiﬁcation en-
zymes are exquisitely speciﬁc. Thus, for example, tRNAHis guanyl-
transferase is speciﬁc for its anticodon to ensure that only
tRNAHis can obtain the extra G1 residue that is used by HisRS to
direct histidylation of the tRNA [54,60–62], t6A37 formation is di-
rected speciﬁcally by U36 and A38 in the anticodon of tRNA in oo-
cytes [63] and, as described above, a number of other
modiﬁcations have well known speciﬁcity for residues around
the anticodon of substrate tRNAs, and play important roles in
decoding mRNAs and maintaining the reading frame during trans-
lation. In these cases the driving force for speciﬁcity is clearly
translation.
Speciﬁcity is also often driven by exceedingly subtle architec-
tural factors. Formation of a 20-O-methylated U34 in tRNA[Ser]Sec in
Xenopus oocytes clearly illustrates this point. There are two iso-
acceptors for this tRNA in vertebrates: one has the modiﬁed
nucleotide mcm5U at the ﬁrst position of the anticodon; and
the second has the nucleotide mcm5Um. Notably, replacement
of U55 (where W is normally found) by G55 prevents ribose meth-
ylation at U34, preventing the formation of mcm5Um without
affecting the levels of mcm5U. Biologically this difference is very
relevant in that 20-O-methylation of mcm5U at position 34 is en-
hanced in the presence of selenium and may have a role in the
formation of selenoproteins. Given the role of W55 in stabilizing
tRNA tertiary structure, this suggests that structural changes
caused by the lack of W55 indeed affect anticodon methylation,
creating connectivity between the two modiﬁed sites, however,
distant they may be.Fig. 2. The role of intracellular localization on tRNAmodiﬁcation speciﬁcity. In eukaryote
organelles (chloroplasts and mitochondria). Highlighted here are two examples where lo
tRNAGln, tRNAGlu and tRNALys with a U at position 34 are substrates for thiolation. In som
position (U33) following import into the mitochondria. Thus tRNATrp transits through the
this tRNA only undergoes C to U editing following mitochondrial import, suggesting the r
possible interrelation among different modiﬁcations in the same substrate. Nifs refers to
UBLs are the ubiquitin-like factors involved in cytoplasmic thiolation. Mtu is the mitoc
tRNAs. The question mark denotes the fact that the C to U editing enzyme still remainsAnother example of a modiﬁcation that depends on another
modiﬁcation occurs in mitochondrial tRNATrp of Trypanosoma
brucei. This tRNA undergoes mitochondrial thiolation and contains
2-thiouridine (s2U) at an unusual position, U33 of the anticodon loop
(Fig. 2). This modiﬁcation is commonly found at U34 (the ﬁrst posi-
tion of the anticodon) in tRNAGlu, tRNAGln and tRNALys in bacteria
and eukarya [64,65]. tRNATrp also undergoes C to U editing at the
ﬁrst position of the anticodon; however, tRNATrp is not 100% edited
and both UCA and CCA anticodon-containing isoacceptors co-exist
in mitochondria. These two tRNAs are then presumably dedicated
to the decoding of the UGA and UGG codons in mitochondria. This
has raised the question about the relationship between C to U edit-
ing and the unusual thiolation at position 33 (Fig. 2). A recent report
showed that if s2U levels decrease, the levels of tRNATrp that under-
go C to U editing (a specialized form of postranscriptional modiﬁca-
tion) go up to nearly 100% [66]. In this latter case, thiolation serves
as a negative determinant for C to U editing and helps keep the
ratios of edited/unedited tRNAs in check, perhaps suggesting some
biological role for both forms of the tRNA.
Yet another way that speciﬁcity is controlled in vivo is by com-
partmentalization. In principle, the modiﬁcation content of a given
tRNA can be affected either by the localization of modiﬁcation en-
zymes in speciﬁc compartments, or by the localization of the tRNA.
Some modiﬁcation enzymes are imported into the nucleus follow-
ing their synthesis in the cytoplasm [67], some are strictly
cytoplasmic [68], and others are imported into the mitochondria
[69–71]. This trafﬁcking creates a situation in which a particular
enzyme, because of its intracellular localization, may never
encounter a particular substrate. Although the discovery of retro-
grade tRNA nuclear import implies that tRNAs that escape to the
cytoplasm without certain modiﬁcations can still in principle bes there are three locations where tRNAs can be modiﬁed: the nucleus, cytoplasm and
calization may impact tRNA modiﬁcation. In the case of cytoplasmic thiolation, only
e cases like the example of tRNATrp in trypanosomes, thiolation occurs at an unusual
nucleus and is only a thiolation substrate for the mitochondrial enzymes. Likewise,
equirement for mitochondria-speciﬁc modiﬁcations for editing, and highlighting the
the universally conserved desulfurase involved in tRNA thiolation in all organisms.
hondrial homolog of the bacterial mnmA, responsible for transferring the sulfur to
unknown.
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74], it is still true that different nuclear-cytoplasmic trafﬁcking
patterns can preclude the encounter between tRNA and its sub-
strate. In addition, tRNAs that are synthesized or imported into
mitochondria are conﬁned to this compartment, and are subject
to modiﬁcation only by enzymes that can be imported there.
One well-studied example of modiﬁcation speciﬁcity appar-
ently conferred by mitochondrial location is the C to U editing of
the T. brucei tRNATrp species discussed above. This editing is con-
ﬁned to mitochondrial tRNATrp and as far as we know does not af-
fect cytoplasmic tRNATrp or any other tRNA species in either
compartment. This ﬁnding suggests strongly that editing is driven
by location of the editing enzyme, as well as by tRNATrp speciﬁcity.
A second example of modiﬁcation speciﬁcity apparently con-
ferred by mitochondrial location is the formation of s2U at U33 of
this same T. brucei tRNATrp. Although both cytoplasm and mito-
chondria share a need for the desulfurase Nifs1 (the eukaryotic
homolog of bacterial iscS) [66,75–77] to initiate the sulfur transfer
reaction, the cytoplasmic thiolation pathway differs from that in
mitochondria (and bacteria) [10,78,79] (Fig. 2). In the cytoplasm,
Nifs1 transfers the sulfur group from cysteine to a series of ubiqui-
tin-like proteins (UBLs) [78,80], and ﬁnally to the tRNA. In mito-
chondria, the route to tRNA thiolation is less clear but appears to
involve Nifs1 and Mtu1 (the eukaryotic homolog to mnmA) [80].
Since there are no tRNA genes in the T. brucei mitochondrial gen-
ome, tRNATrp is transcribed in the nucleus and transits through
the cytoplasm where a portion of it is maintained in the cytoplasm
for translation of nucleus-encoded mRNAs, and another portion is
imported into the mitochondria. Surprisingly tRNATrp is not thio-
lated in the cytoplasm but receives the unusual U33 thiolation fol-
lowing mitochondrial import (Fig. 2). This result suggests strongly
that speciﬁcity for s2U33 modiﬁcation of tRNATrp derives from the
mitochondrial location of the U33 thiolation machinery, thereby
preventing modiﬁcation of cytoplasmic tRNATrp, whereas the cyto-
plasmic thiolation system is speciﬁc for U34 modiﬁcation of cyto-
plasmic tRNAGln, tRNAGlu and tRNALys [66,75–77].5. Summary and concluding remarks
The picture that emerges from this discussion is the intriguing
possibility that modiﬁcations may not necessarily have the same
beneﬁcial effect on all tRNAs. Two lines of evidence are cited above
to support this claim. First, we summarized ﬁndings supporting the
view that although some modiﬁcations may stabilize speciﬁc tRNA
species from degradation by either the nuclear surveillance or the ra-
pid decay pathway, several tRNAs with the same modiﬁcations are
largely resistant to these pathways. Second,we summarized evidence
that somemodiﬁcations in the body of the tRNA, are catalyzed by en-
zymes with low speciﬁcity. We have alsomade three arguments that
each modiﬁcation might be important for each tRNA. First, we
pointed out that only a limited number of growth conditions and as-
says have been tested, and suggested that new roles of modiﬁcations
would be uncovered asmore sophisticated assays are used to explore
the effects of modiﬁcations on tRNA charging, folding, and ﬂexibility,
as well as on other aspects of translation and toxin defense. Second,
we highlighted the high speciﬁcity of tRNA modiﬁcation enzymes
that act near the anticodon, or that otherwise affect translation by
affecting charging ﬁdelity. Third, we provided support for increased
levels of speciﬁcity of particular modiﬁcation enzymes acting around
the anticodon, due to subtle and complex modes of substrate recog-
nition. We also described how intracellular compartmentalization of
tRNAs and modiﬁcation enzymes may affect substrate availability
and indirectly inﬂuence speciﬁcity.
We emphasize that it is not that surprising that modiﬁcations
are not equally useful for all tRNAs. Since as argued above, thesubstrate speciﬁcity of at least some tRNA modiﬁcation enzymes
is necessarily relaxed to accommodate their disparate targets, it
seems plausible that particular modiﬁcations on some tRNA spe-
cies are not as important as the same modiﬁcation on other tRNA
species. It is also conceivable that some modiﬁcations serve no ac-
tual role on certain tRNAs. Thus, while the driving force for main-
taining the modiﬁcation enzymes is their important role on
speciﬁc tRNAs, we suggest that the seemingly redundant modiﬁca-
tion of other tRNA species by these enzymes can occur because of
overlapping substrate speciﬁcity, and the benign effects of these
additional modiﬁcations on the tRNA species that receive them.Acknowledgements
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